Meridia SCOUT Results Will Impact Future Obesity Drug Approval – Gerson Lehrman Group
04 September 2010
Meridia SCOUT Results Will Impact Future Obesity Drug ApprovalGerson Lehrman Groupwww.nejm.org/doi/full/10.1056/NEJMe1007993 The SCOUT trial could (and should) impact the FDA view of, and approval process for, obesity drugs. …NEJM: Meridia worsens CV risks; FDA mulls its futureCardiovascular Businessall 4 news articles » View full post on obesity – Google News


